Enavogliflozin (SGLT2i)

Enavogliflozin (SGLT2i)
Product Description

Enavogliflozin is a best-in-class SGLT2 inhibitor for T2DM.


Highlights of Enavogliflozin:

* NDA filed, Accelerated Approval granted by MFDS, expected market approval within 2022 for T2DM
* T2DM Phase III was completed in Korea as a stand-alone and as combinations with other anti-diabetics
* Obesity Phase II planned in Korea as a combination therapy
* Highly potent, superior glucose control, and longer duration of action
* Confirmed in vivo efficacy in STAM  mouse NASH model
* Confirmed in vivo efficacy in TAA-induced mouse liver fibrosis model
* A compound asset targeting multiple indications both for human use and veterinary use

Daewoong Pharmaceutical Co.,Ltd

  • KR
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Convenience
  • Model
    New Chemical Entity

Daewoong Pharmaceutical Co.,Ltd

  • KR
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from Daewoong Pharmaceutical Co.,Ltd (4)

  • NABOTA

    Product NABOTA

    Botulinum toxin type A

    Indication: Glabella Lines (Approved in KR, US, Canada, on-going registration in EU), 
    Post Stroke Upper Limb Spasticity (Approved in KR), 
    Crow's feet (Approved in KR), Blepharospasm (Approved in KR)

    - NabotaTM is the only 900kDa neurotoxi...
  • Crezet

    Product Crezet

    1) Indication :  Treatment of primary hypercholesterolemia or to decrease elevated fat level in blood (mixed hyperlipidemia) in adult patients 
    2) Composition : Ezetimibe, Rosuvastain calcium (strength: 10/20mg, 10/10mg,10/5mg)
    3) Dosage & Administration : Once a day with or without m...
  • Epodion

    Product Epodion

    2000, 3000, 4000, 10000IU / Pre-filled syringe Inj.

    Albumin-FREE
    rhEPO (recombinant human erythropoietin)

    Indication:
    Anemia in chronic renal failure

    - EpodionTM is PFS type of Erytrhopoietin - alpha (rhEPO) for improving the hemoglobin and hematocrit level ...
  • Eposis

    Product Eposis

    2000, 3000, 4000, 5000, 6000, 8000, 10000IU / Pre-filled syringe Inj.

    rhEPO (recombinant human erythropoietin)

    Indication:
    Anemia in chronic renal failure

    - EposisTM demonstrated significant improvement and safety for patients with anemia in Chronic Renal Failure (CRF).
    ...

Daewoong Pharmaceutical Co.,Ltd resources (2)

  • News Daewoong Pharm’s COVID-19 cure enters Phase 2 trial in Mexico

    An investigator-initiated Phase 2 clinical trial of Daewoong Pharm’s COVID-19 drug candidate has been kicked off at several health centers in Mexico, including Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The sponsor-investigator study will evaluate the efficacy and safety profile of Foistar Tab. (camostat mesylate) in 180 COVID-19 patients with mild to moderate ...